Basic Information
| RNALocate ID: | RLID-D:11001574 |
| RNA Symbol: | hsa-miR-616-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-616-3p |
| RNA ID: | miRBase:MIMAT0004805 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID-D:11004102 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-616-3p | Medulloblastoma | MNDR-E-MI-63370 |
| MNDR | hsa-miR-616-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-63371 |
| MNDR | hsa-miR-616-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-63372 |
| MNDR | hsa-miR-616-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-63373 |
| MNDR | hsa-miR-616-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-63374 |
| MNDR | hsa-miR-616-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-63375 |
| MNDR | hsa-miR-616-3p | Her2-receptor positive breast cancer | MNDR-E-MI-63376 |
| MNDR | hsa-miR-616-3p | Prostate cancer | MNDR-E-MI-63377 |
| MNDR | hsa-miR-616-3p | Gastric cancer | MNDR-E-MI-63378 |
| MNDR | hsa-miR-616-3p | Dysautonomia familial | MNDR-E-MI-63379 |
| MNDR | hsa-miR-616-3p | Lung cancer | MNDR-E-MI-63380 |
| MNDR | hsa-miR-616-3p | Parkinson disease | MNDR-E-MI-63381 |
| MNDR | hsa-miR-616-3p | Breast cancer | MNDR-E-MI-63382 |
| MNDR | hsa-miR-616-3p | Pancreatic cancer | MNDR-E-MI-63383 |
| MNDR | hsa-miR-616-3p | Melanoma | MNDR-E-MI-63384 |
| MNDR | hsa-miR-616-3p | Rectum adenocarcinoma | MNDR-E-MI-63385 |
| MNDR | hsa-miR-616-3p | Colon cancer | MNDR-E-MI-63386 |
| MNDR | hsa-miR-616-3p | Glioblastoma | MNDR-E-MI-63387 |
| MNDR | hsa-miR-616-3p | Glioma | MNDR-E-MI-63388 |
| MNDR | hsa-miR-616-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-63389 |
| MNDR | hsa-miR-616-3p | Coronary artery disease | MNDR-E-MI-63390 |
| MNDR | hsa-miR-616-3p | Lung squamous cell carcinoma | MNDR-E-MI-63391 |
| MNDR | hsa-miR-616-3p | Lung adenocarcinoma | MNDR-E-MI-63392 |
| MNDR | hsa-miR-616-3p | Thyroid carcinoma | MNDR-E-MI-63393 |
| MNDR | hsa-miR-616-3p | Carcinoma renal cell | MNDR-E-MI-63394 |
| MNDR | hsa-miR-616-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-63395 |
| MNDR | hsa-miR-616-3p | Renal clear cell carcinoma | MNDR-E-MI-63396 |
| MNDR | hsa-miR-616-3p | Cholangiocarcinoma | MNDR-E-MI-63397 |
| MNDR | hsa-miR-616-3p | Hepatocellular carcinoma | MNDR-E-MI-63398 |
| MNDR | hsa-miR-616-3p | Malignant pleural mesothelioma | MNDR-E-MI-63399 |
| MNDR | hsa-miR-616-3p | Skin cutaneous melanoma | MNDR-E-MI-63400 |
| MNDR | hsa-miR-616-3p | Skin melanoma | MNDR-E-MI-63401 |
| MNDR | hsa-miR-616-3p | Colorectal cancer | MNDR-E-MI-63402 |
| MNDR | hsa-miR-616-3p | Nasopharynx carcinoma | MNDR-E-MI-63403 |
| MNDR | hsa-miR-616-3p | Multiple myeloma | MNDR-E-MI-63404 |
| MNDR | hsa-miR-616-3p | Nasopharyngeal cancer | MNDR-E-MI-63405 |
| MNDR | hsa-miR-616-3p | Stroke lacunar | MNDR-E-MI-63406 |
| MNDR | hsa-miR-616-3p | Breast cancer her3+ negative | MNDR-E-MI-63407 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | PON1 | Homo sapiens | RR01120444 |
TOP